home technology analytics about us news
deltaDOT is a spin out company from Imperial College London UK - a team of scientists and  engineers dedicated to the advancement of analytical techniques using patented methods and  instrumentation in High Performance Capillary Electrophoresis (HPCE). We design and  produce HPCE instruments which we are marketing worldwide. We also use the same  instruments to offer Analytical Services and Contract Research. Our offices and laboratories  are based in the London Bioscience Innovation Centre (LBIC). 
Who we are 
HPCE instruments 
High Performance Capillary Electrophoresis (HPCE) analytical instruments are designed,  manufactured and marketed by deltaDOT. These instruments use deltaDOT’s proprietary  imaging and analysis technology called Label Free Intrinsic Imaging (LFII®). High  Performance Capillary Electrophoresis and Label Free Intrinsic Imaging applied to a CE  analytical system  offers dramatically improved discovery power in comparison to other  conventional CE systems.
deltaDOT team of scientists has developed considerable expertise in CE based analysis and in  solving clients’ analytical problems. Using our own HPCE LFII® analytical instruments we also  offer Analytical Services and Contract Research to industry and academia from our  laboratories in the London Bioscience Innovation Centre.  
Analytical Services & Contract Research 
HPCE Applications 
High Performance Capillary Electrophoresis (HPCE) is applied in Life Sciences research,  drug testing, diagnostics and bio-pharmaceutical manufacturing. This technology is used in  detection, separation and analysis of proteins, nucleic acids, carbohydrates, viruses and  bacteria, chemicals and a wide range of other analytes. More detail can be found on our  Technology pages. 
Application Notes & Downloads 
Antibody Analysis, Amino Acid Analysis, Transferrin, Small Molecules, Peptides, Complex  Protein Lysates, Recombinant Human Erythropoietin, Antibiotics in food products, Glycoforms,  DNA, RNA, Chemicals, Baculovirus Titre.  Glomerular filtration rate (GFR) determined by Iohexol clearance was developed in  collaboration with Royal Veterinary College for renal failure diagnosis in companion animals  (...more) 
18 December 2013 deltaDOT chosen as supplier to National Center for  Therapeutics Manufacturing, College Station, Texas. London, UK, -  deltaDOT Ltd announced the sale of their HPCE-512 instruments to the  Texas A&M Center for Innovation in Advanced Development and  Manufacturing (CIADM).  The implementation of the HPCE-512 technology  at the CIADM will facilitate the establishment of enhanced analytical  capabilities in the Center’s facilities ...more  27th August 2013 deltaDOT exhibiting at London Vet Show on 21 & 22  Novemberat Olympia. deltaDOT will be showcasing its HPCE technology as  applicable to the veterinary market. Please come and visit us at our stand  J12 15th July 2013 deltaDOT technology has been flagged as a powerful tool in pharmaceutical formulation QA/QC. Follow link to PROCESS BIOCHEMISTRY  1st July 2013 deltaDOT’s technology is being evaluated by a global  pharmaceutical group for possible use in bio-pharmaceutical  manufacturing. The results of this collaboration are expected later this  year. 6th February 2013 deltaDOT to present at the International Society for BioProcess Technology annual meeting. Dr Stuart Hassard, Chief Scientific Officer, will be presenting the use of  LFII®  in Process Analytical Technology (PAT) in the Flexible Facilities and  Systems Ancillary track at IsBioTech 2013 on Friday the 15th of March  2013. The meeting will be held at Waterview Conference Center 1919  North Lynn Street, Arlington, Virginia 22209, USA, March 11-15. Full  details can be found at www.isbiotech.org/  23rd October 2012 deltaDOT sign distribution agreement with HORIBA UK deltaDOT and HORIBA UK Ltd. of Stanmore, Middlesex have signed a distribution agreement, with HORIBA being appointed sole UK and Republic of Ireland distributor for deltaDOT's HPCE analytical instruments. "Being associated with a large player in the field of scientific instrumentation is very helpful, and deltaDOT is expecting to benefit from HORIBA's brand, marketing expertise and from the field support offered to deltaDOT technology by HORIBA's sizeable engineering team" commented deltaDOT's Managing Director Nigel Stokes. 24th September 2012 deltaDOT Ltd. announced the recent sale of their equity holding in  deltaDOT-QSTP LLC, its Doha based affiliate company to QS&T-S.P.C. of  Qatar. Mr Nigel Stokes, deltaDOT's Managing Director, commented:  "deltaDOT have worked closely with our colleagues in Doha and are happy  to have supported new developments on the application of deltaDOT's  Label free technology into the oil and gas industry. We wish the company  good fortune and look forward to continued interactions and R&D  programs" (...more) 18 June 2012 Texas A&M System Awarded National Center for Innovation. deltaDOT Ltd. is a partner in BARDA funded international consortium. $285.6 million public-private partnership to enhance the nation’s biosecurity preparedness and create jobs in Texas (...more)